COMMUNIQUÉS West-GlobeNewswire

Organic & Natural Health Association Shares 5 Ways Americans Can Protect Their Health as Insurance Costs Rise
21/10/2026
WASHINGTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- As Americans prepare for another year of rising health insurance costs, staying healthy is becoming a financial concern as well as a personal priority. With Affordable Care [...]
Healthcare’s Financial Leaders Pledge Unprecedented Collaboration to Address America’s Healthcare Affordability Crisis
21/10/2026
‘Declaration on Healthcare Affordability and Sustainability’ offers a results-oriented roadmap toward innovative, data-driven solutions CHICAGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- The Healthcare Financial Management [...]
Atalan to Present New Research on Measuring AI’s Real-World Impact and Predicting Nurse Turnover
21/10/2026
Presentations at AAPL Annual Leadership Conference and American Nurses Enterprise Research Symposium will explore how machine learning can help health systems anticipate workforce disruption and measure technology’s [...]
Science News unveils its list of 10 scientists making an impact on our world
21/10/2026
WASHINGTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- For more than a decade, Science News has celebrated early- and mid-career scientists tackling some of today’s biggest challenges. This year’s SN 10: Scientists to Watch list [...]
NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward
21/10/2026
New agreement with the Department of Health – Abu Dhabi establishes a framework for research collaboration as two children receive investigational NEO100 and a third is expected this week. DENVER, Oct. 21, 2026 (GLOBE [...]
New JAHA-Published EggNest® Study and Texas State Regulatory Variance Validate Shift Toward Apron-Free Workflows in the Interventional Lab
21/10/2026
MINNEAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Egg Medical today announced the publication of a prospective study in the Journal of the American Heart Association (JAHA) evaluating its EggNest Enhanced Radiation [...]
Nobel Laureates Join China’s Brain-Health Conversation: Michael Levitt and May-Britt Moser
21/10/2026
From Molecular Research to Neuroscience: Connecting International Academic Perspectives with China’s Biomanufacturing Practice BEIJING, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Michael Levitt and May-Britt Moser represent two [...]
Progyny, Inc. Announces Details for Its Third Quarter 2026 Results Report
21/10/2026
NEW YORK, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, [...]
Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica (PMR)
21/10/2026
Cosentyx® (secukinumab) becomes first and only IL-17A inhibitor approved in Europe for adults with PMR, 1 a common inflammatory rheumatic disease with limited advanced treatment options 2-6 Approval based on Phase III [...]
Alignment Health Expands Medicare Advantage Plan to Nye County for 2027
21/10/2026
Expansion extends Alignment’s Nevada presence to three counties, home to more than 554,000 Medicare beneficiaries LAS VEGAS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Alignment Health Plan, an award-winning Medicare Advantage [...]
Grâce à l’IA, le KFSH anticipe la fréquentation des urgences 24 heures à l’avance et réduit de 42 % le délai d’attente avant la consultation médicale
21/10/2026
RIYAD, Arabie saoudite, 21 oct. 2026 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and Research Centre (KFSH) s’appuie sur l’intelligence artificielle pour anticiper la demande au sein de son service des [...]
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
21/10/2026
A seasoned global people leader and organizational strategist, Ms. Aspesi will help scale Entrada’s people and organization for its next phase of growth BOSTON, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, [...]
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
21/10/2026
—Expands BioCryst portfolio of targeted oral prophylactic therapy options to meet patients’ individual needs and preferences— —ORLADEYO is the first and only targeted oral prophylactic therapy with options for HAE [...]
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
21/10/2026
DURHAM, N.C., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT ) today announced that it will report its financial results for the second fiscal quarter ended September 30, 2026 on Monday, November 9, [...]
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)
21/10/2026
Brepocitinib 45 mg once-daily achieved statistically significant benefit compared to placebo on the primary and all key secondary endpoints for each of CLARITY-1 and CLARITY-2, the two identical Phase 3 trials [...]
Satellos to Participate in Upcoming Investor Conferences
21/10/2026
TORONTO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a clinical-stage company developing potentially life-improving medicines to treat degenerative muscle diseases, today [...]
Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)
21/10/2026
SUN-627 demonstrated favorable safety, tolerability, and pharmacokinetics for oral, once-daily dosing in healthy volunteers Achieved full central nervous system (CNS) penetration and >90% inhibition of TYK2 pathway [...]
What joint replacement involves, from the surgeon's credentials to the recovery plan
21/10/2026
Mount Pleasant, SC, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Novant Health Orthopedics & Sports Medicine Institute has published a patient guide on how to choose a joint replacement surgeon and hospital in the Charleston [...]
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
21/10/2026
VMS063 is a novel, potential first- and best-in-class monoclonal antibody investigational candidate discovered by Invivyd VMS063 demonstrated potent in vitro antiviral activity against contemporary measles virus [...]

Pages